Cited by 1,179SARS-CoV-2 and COVID-19 ResearchEvolution and Genetic DynamicsAnimal Virus Infections Studies

The DOI matches its Crossref record; 252 of the 252 references it cites were found in a registry or an index.

The evolution of SARS-CoV-2

Open access

Markov, Peter V., Ghafari, Mahan, Beer, Martin, Lythgoe, Katrina, Simmonds, Peter, Stilianakis, Nikolaos I., Katzourakis, Aris·2023·Nature Reviews Microbiology

DOI 10.1038/s41579-023-00878-2

Open this paper in CoChat — free account Open PDF

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused millions of deaths and substantial morbidity worldwide. Intense scientific effort to understand the biology of SARS-CoV-2 has resulted in daunting numbers of genomic sequences. We witnessed evolutionary events that could mostly be inferred indirectly before, such as the emergence of variants with distinct phenotypes, for example transmissibility, severity and immune evasion. This Review explores the mechanisms that generate genetic variation in SARS-CoV-2, underlying the within-host and population-level processes that underpin these events. We examine the selective forces that likely drove the evolution of higher transmissibility and, in some cases, higher severity during the first year of the pandemic and the role of antigenic evolution during the second and third years, together with the implications of immune escape and reinfections, and the increasing evidence for and potential relevance of recombination. In order to understand how major lineages, such as variants of concern (VOCs), are generated, we contrast the evidence for the chronic infection model underlying the emergence of VOCs with the possibility of an animal reservoir playing a role in SARS-CoV-2 evolution, and conclude that the former is more likely. We evaluate uncertainties and outline scenarios for the possible future evolutionary trajectories of SARS-CoV-2.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41579-023-00878-2

Cites

252 of 252 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
EVOLUTION IN MENDELIAN POPULATIONS
Wright, S. (1931) · Genetics · doi:10.1093/genetics/16.2.97 · Cited by 9,237
Virological assessment of hospitalized patients with COVID-2019
Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2196-x · Cited by 6,661
Origin and evolution of pathogenic coronaviruses
Cui, J., Li, F., & Shi, Z. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0118-9 · Cited by 5,729
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Hengartner, N., Giorgi, E. E., Bhattacharya, T., Foley, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.043 · Cited by 4,281
Coronaviruses: An Overview of Their Replication and Pathogenesis
Fehr, A. R., & Perlman, S. M. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2438-7_1 · Cited by 3,910
Structural basis of receptor recognition by SARS-CoV-2
Shang, J., Ye, G., Shi, K., Wan, Y., Luo, C., Aihara, H., Geng, Q., Auerbach, A., & Li, F. (2020) · Nature · doi:10.1038/s41586-020-2179-y · Cited by 3,661
SARS-CoV-2 variants, spike mutations and immune escape
Harvey, W. T., Carabelli, A. M., Jackson, B., Gupta, R. K., Thomson, E. C., Harrison, E. M., Ludden, C., Reeve, R., Rambaut, A., COVID-19 Genomics UK (COG-UK) Consortium, et al. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00573-0 · Cited by 3,528
Nextstrain: real-time tracking of pathogen evolutionPreprint
Hadfield, J., Megill, C., Bell, S. M., et al. (2017) · bioRxiv · doi:10.1101/224048 · Cited by 3,172
Nextstrain: real-time tracking of pathogen evolution
Hadfield, J., Megill, C., Bell, S. M., Huddleston, J., Potter, B., Callender, C., Sagulenko, P., Bedford, T., & Neher, R. A. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty407 · Cited by 3,154

Show all 225 references

Sorted by citations

Items 501–600 of 998

Beyond SARS-CoV-2: could MERS-CoV spark the next coronavirus pandemic? A one health perspective
Miteu, G. D. (2025) · Discover Public Health · doi:10.1186/s12982-025-00884-0 · Cited by 3
Using machine learning methods to investigate the impact of comorbidities and clinical indicators on the mortality rate of COVID-19
Hsieh, Y.-C., Chen, S., Tsao, S.-Y., Hu, J., Hsu, W., & Lee, C. (2025) · Frontiers in Medical Technology · doi:10.3389/fmedt.2025.1621158 · Cited by 3
P3a site-specific and cassette mutagenesis for seamless protein, RNA and plasmid engineering
Yang, X. (2025) · Genes & Cancer · doi:10.18632/genesandcancer.243 · Cited by 3
Virust5: Harnessing Large Language Models to Predicting Sars-Cov-2 Evolution
Marathe, V., Bajracharya, D., & Yan, C. (2025) · IEEE International Conference on Bioinformatics and Bioengineering (BIBE) · doi:10.1109/bibe66822.2025.00117 · Cited by 3
Immunogenicity of coronavirus disease 2019 vaccines in children: A review with ChatGPT
Leung, D., Duque, J. S. R., Tu, W., & Lau, Y. (2023) · Pediatric Discovery · doi:10.1002/pdi3.8 · Cited by 3
Design of VA CoronavirUs Research and Efficacy Studies-1 (VA CURES-1): A double-blind, randomized placebo-controlled trial of COVID-19 convalescent plasma in hospitalized patients with early respiratory compromise
Janoff, E. N., Brown, S. T., Belitskaya‐Lévy, I., Curtis, J. L., Bonomo, R. A., Miller, E. K., Goldberg, A. M., Zehm, L., Wills, A., Hutchinson, C., et al. (2023) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2023.101190 · Cited by 3
Long-range linkage effects in adapting sexual populations
Rouzine, I. M. (2023) · Scientific Reports · doi:10.1038/s41598-023-39392-z · Cited by 3
Immune-Cell-Based Therapy for COVID-19: Current Status
Wang, Y., Liang, Q., Chen, F., Zheng, J., Chen, Y., Chen, Z., Li, R., & Li, X. (2023) · Viruses · doi:10.3390/v15112148 · Cited by 3
Mutational analysis of severe acute respiratory syndrome coronavirus 2 in immunocompromised patients with persistent viral detection using whole genome sequencing
Chang, E., Lee, J., Kim, J., Seok, J. H., Bae, J., Kim, J., Park, H., Jang, C., Kang, S., Lim, S. Y., et al. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1462 · Cited by 3
Two-Stage Recognition Mechanism of the SARS-CoV-2 Receptor-Binding Domain to Angiotensin-Converting Enzyme-2 (ACE2)
Biskupek, I., & Giełdoń, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25010679 · Cited by 3
Emerging and Neglected Viral Zoonoses in Europe
Vilibić‐Čavlek, T., Savić, V., Lepej, S. Ž., Bogdanić, M., Stevanović, V., & Barbić, L. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.112779 · Cited by 3
Evaluation of the implementation of a community health worker-led COVID-19 contact tracing intervention in Chiapas, Mexico, from March 2020 to December 2021
Aranda, Z., Vázquez, S., Gopaluni, A., Martínez, L., Ramírez, M., Jimenez, A., Bernal-Serrano, D., Rodríguez, A. L., Chacón-Hernández, S. S. T., Vargas, B., et al. (2024) · BMC Health Services Research · doi:10.1186/s12913-024-10590-3 · Cited by 5
Modeling of Transformations during the Formation of Local Waves of SARS-CoV-2 Spreading at the Endemic Stage of the Pandemic
Perevaryukha, A. Y. (2023) · Technical Physics Letters · doi:10.1134/s1063785023700153 · Cited by 3
Targeting Viral and Cellular Cysteine Proteases for Treatment of New Variants of SARS-CoV-2
Gentile, D., Chiummiento, L., Santarsiere, A., Funicello, M., Lupattelli, P., Rescifina, A., Venuti, A., Piperno, A., Sciortino, M. T., & Pennisi, R. (2024) · Viruses · doi:10.3390/v16030338 · Cited by 3
Possible Spreading of SARS-CoV-2 from Humans to Captive Non-Human Primates in the Peruvian Amazon
Gonzales, A., Bazalar-Gonzales, J., Espejo, T. S., Galarza, M. L., Cueva, C. L. R., Carhuaricra, D., Luis Luna, E., & Lenin Maturrano, H. (2024) · Animals · doi:10.3390/ani14050732 · Cited by 3
Systems biology of B cells in COVID-19
Woodruff, M. C., Faliti, C. E., & Sanz, I. (2024) · Seminars in Immunology · doi:10.1016/j.smim.2024.101875 · Cited by 3
Development and Evaluation of an In-House Real-Time RT-PCR Targeting nsp10 Gene for SARS-CoV-2 Detection
Yip, C. C., Poon, J. H.-C., Leung, K., Chan, W.-M., Ip, J. D., Chu, A. W., Cheng, V. C., Yuen, K., & To, K. K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063552 · Cited by 3
Upping the ante: enhanced expression of interferon-antagonizing ORF6 and ORF9b proteins by SARS-CoV-2 variants of concern
Caobi, A., & Saeed, M. (2024) · Current Opinion in Microbiology · doi:10.1016/j.mib.2024.102454 · Cited by 3
Effects of Strain Differences, Humidity Changes, and Saliva Contamination on the Inactivation of SARS-CoV-2 by Ion Irradiation
Wadi, A. F. A. A., Onomura, D., Funamori, H., Khatun, M. M., Okada, S., Iizasa, H., & Yoshiyama, H. (2024) · Viruses · doi:10.3390/v16040520 · Cited by 3
Analysis of SARS-CoV-2 omicron mutations that emerged during long-term replication in a lung cancer xenograft mouse model
Baek, K., Kim, D., Kim, J.-S., Kang, B. M., Park, H., Park, S., Shin, H.-E., Lee, M.-H., Maharjan, S., Kim, M., et al. (2024) · Virus Genes · doi:10.1007/s11262-024-02067-6 · Cited by 3
Development of Detection Antibody Targeting the Linear Epitope in SARS-CoV-2 Nucleocapsid Protein with Ultra-High Sensitivity
Wu, F. Y., Jiang, Y., Yang, H., & Ma, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084436 · Cited by 3
An antifouling electrochemical sensor integrating ‘‘3-in-1″ dual-targeted aptamer for the detection of the SARS-CoV-2 spike protein
Zhao, J., Wu, T., Xiong, Y., Zhang, W., Pan, Z., Cai, S., & Yang, R. (2024) · Applied Surface Science · doi:10.1016/j.apsusc.2024.160226 · Cited by 3
A speed limit on serial strain replacement from original antigenic sin
McGough, L., & Cobey, S. E. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2400202121 · Cited by 3
COVID-19 point-of-care tests can identify low-antibody individuals: In-depth immunoanalysis of boosting benefits in a healthy cohort
Mallory, M. L., Munt, J. E., Narowski, T. M., Castillo, I. N., Cuadra, E., Pisanic, N., Fields, P., Powers, J. M., Dickson, A. M., Harris, R., et al. (2024) · Science Advances · doi:10.1126/sciadv.adi1379 · Cited by 5
Comparing Phylogeographies to Reveal Incompatible Geographical Histories within Genomes
Singer, B. J., Nardo, A. D., Hein, J., & Luca Ferretti, A. (2024) · Molecular Biology and Evolution · doi:10.1093/molbev/msae126 · Cited by 3
Inexpensive and colorimetric RNA detection at ambient temperature with a cell-free protein synthesis platform
Toparlak, Ö. D., Notarangelo, M., Quattrone, A., Pizzato, M., & Mansy, S. S. (2024) · Biotechnology for Sustainable Materials · doi:10.1186/s44316-024-00007-w · Cited by 3
Competitive Interaction of the SGFRKMAF Peptide with 3CLpro Dimerization Intermediates: A Brownian Dynamics Investigation
ElSawy, K. M. (2024) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.4c01938 · Cited by 3
The significance of recurrent de novo amino acid substitutions that emerged during chronic SARS-CoV-2 infection: an observational study
Ip, J. D., Chu, W.-M., Chan, W.-M., Chu, A. W., Leung, R. C.-Y., Peng, Q., Tam, A. R., Chan, B. P.-C., Cai, J., Yuen, K., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105273 · Cited by 3
A program for real-time surveillance of SARS-CoV-2 genetics
Brochu, H., Song, K., Zhang, Q., Zeng, Q.-D., Shafi, A., Robinson, M., Humphrey, J., Croy, B., Peavy, L., Perera, M., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-70697-9 · Cited by 4
Comparative analysis of mental health impairment among COVID-19 confirmed cases across the pandemic period in South Korea
Lee, D., Hyun, S. Y., Kim, H.-J., Kwak, E., Lee, S., Baik, M., Paik, J., Sim, M., & Jung, S. J. (2024) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2024.104233 · Cited by 3
Interactions of SARS-CoV-2 with Human Target Cells—A Metabolic View
Eisenreich, W., Leberfing, J., Rudel, T., Heesemann, J., & Goebel, W. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25189977 · Cited by 3
Integrated analyses of the transmission history of SARS-CoV-2 and its association with molecular evolution of the virus underlining the pandemic outbreaks in Italy, 2019-2023
Cella, E., Fonseca, V., Branda, F., Tosta, S. F. D. O., Moreno, K. M. F., Schuab, G., Ali, S., Slavov, S. N., Scarpa, F., Santos, L. A., et al. (2024) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2024.107262 · Cited by 3
Protein Nanoparticles for Targeted SARS‐CoV‐2 Trapping and Neutralization
Fornt‐Suñé, M., Puertas, M. C., Martínez‐Picado, J., García‐Pardo, J., & Ventura, S. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202402744 · Cited by 3
TO MARKET, TO MARKET—2023: SMALL MOLECULES
Araujo, E., Bartels, B., Bell, I. M., Castanedo, G. M., Zeng, M., Dhar, T. G. M., Holmberg‐Douglas, N., Welin, E. R., Koester, D. C., León, B., et al. (2024) · Medicinal chemistry reviews · doi:10.1021/mc-2024-vol59.ch19 · Cited by 3
Intra-host variability of SARS-CoV-2: Patterns, causes and impact on COVID-19
Jones, L. R. (2024) · Virology · doi:10.1016/j.virol.2024.110366 · Cited by 3
Predictors of COVID-19 Readmission Among Patients Previously Hospitalized for SARS-CoV-2
Colaneri, M., Canuti, M., Torrigiani, G., Dall’Olio, L., Bobbio, C., Baldi, S. L., Nobili, A., Puoti, M., Marchetti, G. M., Piva, S., et al. (2025) · Infectious Diseases and Therapy · doi:10.1007/s40121-024-01107-w · Cited by 3
A novel genotyping system based on site polymorphism on spike gene reveals the evolutionary pathway of porcine epidemic diarrhea virus
Lei, M., Li, H., Chen, X., Li, X., Yu, X., Ruan, S., Wu, H., Ghonaim, A. H., Yan, Z., Li, W., et al. (2025) · iMetaOmics. · doi:10.1002/imo2.70013 · Cited by 3
Short-Read and Long-Read Whole Genome Sequencing for SARS-CoV-2 Variants Identification
Peng, M., Davis, M. L., Bentz, M. L., Burgin, A., Burroughs, M., Padilla, J., Nobles, S., Unoarumhi, Y., & Tang, K. (2025) · Viruses · doi:10.3390/v17040584 · Cited by 3
Mutant emergence timing and population immunisation status impact epidemiological dynamics
Reyné, B., Djidjou‐Demasse, R., Sofonea, M. T., & Alizon, S. (2025) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2025.112140 · Cited by 3
Diverse patterns of intra-host genetic diversity in chronically infected SARS-CoV-2 patients
Zvi, A. B., Rutsinsky, N., Jacobi, B., Fabian, I., Segev, S., Harari, S., Meijer, S. E., Paran, Y., & Stern, A. (2025) · Virus Evolution · doi:10.1093/ve/veaf047 · Cited by 4
The Relationship Between Foot Conformation, Foot Placement and Motion Symmetry in the Equine Hindlimb
Agass, R., Wilson, A. M., Weller, R., & Pfau, T. (2014) · Equine Veterinary Journal · doi:10.1111/evj.12323_44 · Cited by 3
Building Blocks of Understanding: Constructing a Reverse Genetics Platform for studying determinants of SARS-CoV-2 replicationPreprint
Olguin-Nava, M., Bohn, P. S., Hennig, T., Börtlein, C., Gribling-Burrer, A.-S., Schmidt, N., Caliskan, N., Dölken, L., Munschauer, M., & Smyth, R. P. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.05.578560 · Cited by 3
Early Evolution of BA.2.86 Sheds Light on the Origins of Highly Divergent SARS-CoV-2 LineagesPreprint
Escalera‐Zamudio, M., Tan, C. C. S., van Dorp, L., & Balloux, F. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.18.604213 · Cited by 3
Severe acute respiratory syndrome (SARS) mathematical models and disease parameters: a systematic review and meta-analysisPreprint
Morgenstern, C., Rawson, T., Routledge, I., Kont, M. D., Imai, N., Skarp, J. E., Doohan, P., McCain, K., Johnson, R., Unwin, H. J. T., et al. (2024) · medRxiv · doi:10.1101/2024.08.13.24311934 · Cited by 3
Optimizing Yeast Homologous Recombination for Splicing Large Coronavirus Genome Fragments
Xiong, G., Huang, X., Hu, A., Meng, Z., Cui, J., Feng, Y., Chen, Z., Lu, Y., Yang, Q., & Liu, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413742 · Cited by 2
Systematic surveillance of SARS-CoV-2 reveals dynamics of variant mutagenesis and transmission in a large urban population
Aynaud, M.-M., Caldwell, L., Al‐Zahrani, K. N., Barutcu, S., Chan, K., Obersterescu, A., Ogunjimi, A. A., Jin, M., Zakoor, K.-R., Patel, S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-55031-1 · Cited by 2
Direct Antiviral Effects of Baicalin and Baicalein against SARS-COV-2: A Systematic Review
Ahmadi, M., Shahbahrami, R., Esfehani, M. A. N., Hosseini, S. M., Khajeh, F., Raziabad, R. H., Nezhadi, J., & Ghanati, K. (2025) · Current Nutrition & Food Science · doi:10.2174/0115734013366067250123113307 · Cited by 2
Glycosylated Receptor-Binding-Domain-Targeting Mucosal Vaccines Protect Against SARS-CoV-2 Omicron and MERS-CoV
Guan, X., Verma, A. K., Liu, Q., Palacios, M., Odle, A. E., Perlman, S. M., & Du, L. (2025) · Vaccines · doi:10.3390/vaccines13030293 · Cited by 2
Structural and Energetic Insights into SARS-CoV-2 Evolution: Analysis of hACE2–RBD Binding in Wild-Type, Delta, and Omicron Subvariants
Tang, C., Lupala, C. S., Wang, D., Li, X., Tang, L., & Li, X. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083776 · Cited by 2
Infectivity and structure of SARS-CoV-2 after hydrogen peroxide treatment
Aliyari, S. R., Xie, G., Xia, X., Wang, L., Zhou, Z. H., & Cheng, G. (2025) · mBio · doi:10.1128/mbio.03994-24 · Cited by 2
Hypericin Suppresses SARS-CoV-2 Replication and Synergizes with Antivirals via Dual Targeting of RdRp and 3CLpro
Souza, H. D. S., Martins, J. S. C. C., Sousa, T. D. C., Sardar, S., Rodrigues, N. F., Silva-Trujillo, L., Souza, T. M. L., Siqueira, M. M., Fernández, J. H., & Matos, A. D. R. (2025) · Microorganisms · doi:10.3390/microorganisms13051004 · Cited by 3
Emergence and transmission dynamics of the FY.4 Omicron variant in Kenya
Musundi, S., Mwanga, M. J., Lambisia, A. W., Morobe, J. M., Murunga, N., Moraa, E., Ndwiga, L., Cheruiyot, R., Musyoki, J., Mutunga, M. N., et al. (2025) · Virus Evolution · doi:10.1093/ve/veaf035 · Cited by 2
Impact of COVID-19 on healthcare programs in Zimbabwe: a mixed methods study
Midzi, N., Haruzivishe, C., Gonese, E., Sembuche, S. L., Mutsaka‐Makuvaza, M. J., Ayebare, R. R., Muwonge, T., Nakasendwa, S., Mateta, C., Madanhire, T., et al. (2025) · BMC Public Health · doi:10.1186/s12889-025-22791-4 · Cited by 4
What makes a host a good reservoir? Determinants of the reservoir potential of Nicotiana glauca for tobacco mild green mosaic virus
de Andrés‐Torán, R., Fraile, A., Bera, S., Mora, M. Á., McLeish, M., & García‐Arenal, F. (2025) · Virus Evolution · doi:10.1093/ve/veaf044 · Cited by 2
Outcomes of Liver Cirrhosis Patients Hospitalized for Influenza Compared With COVID-19 Between 2020 and 2021 in the United States
Verma, R., Ramphul, K., Tun, K. M., Obeidat, Y., Liu, L., Sakthivel, H., & Joshi, T. (2025) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000002199 · Cited by 2
Coronaviruses in wild rodent and eulipotyphlan small mammals: a review of diversity, ecological implications and surveillance considerations
Jeeves, S. P., Kotwa, J. D., Pearl, D. L., Pickering, B., Bowman, J., Mubareka, S., & Jardine, C. M. (2025) · Journal of General Virology · doi:10.1099/jgv.0.002130 · Cited by 3
SARS-CoV-2 Nsp1 Is a Major Suppressor of HLA Class I and Class II Expression
Schirmeister, I., Eckert, N., Weigang, S., Fuchs, J., Kern, L., Kochs, G., & Halenius, A. (2025) · Viruses · doi:10.3390/v17081083 · Cited by 2
A highly divergent sample from a nearly extinct SARS-CoV-2 lineage in a patient with long-term COVID-19
Nabieva, E., Komissarov, A. B., Klink, G. V., Zaitsev, S. V., Sergeeva, M. V., Fadeev, A. V., Komissarova, K., Ivanova, A. A., Pisareva, M., Kudrya, K., et al. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1623390 · Cited by 7
A conserved long-range RNA interaction in SARS-CoV-2 recruits ADAR1 to enhance virus proliferation
Yang, S. L., DeFalco, L., Wang, S.-N., Wong, Y., Han, J., Mok, C.-K., Tan, K. Y., Lim, S.-Y., Zhao, Z.-Y., Zhang, Y., et al. (2025) · bioRxiv · doi:10.1038/s41467-025-63297-2 · Cited by 2
Highly Recurrent Multinucleotide Mutations in SARS-CoV-2
Maio, N. D., Anoufa, O., Smith, K., Turakhia, Y., & Goldman, N. (2025) · Molecular Biology and Evolution · doi:10.1093/molbev/msaf272 · Cited by 2
Association between stress hyperglycemia ratio and prognosis of patients hospitalized with COVID ‐19: A meta‐analysis
Chen, L., Wang, M., & Chen, J. (2025) · Journal of Diabetes Investigation · doi:10.1111/jdi.70146 · Cited by 2
Genotype networks drive oscillating endemicity and epidemic trajectories in viral evolution
Lamata-Otín, S., Rotita-Ion, O. C., Arenas, À., Soriano‐Paños, D., & Gómez‐Gardeñes, J. (2025) · Communications Physics · doi:10.1038/s42005-025-02406-5 · Cited by 2
Dynamic impact of bivalent COVID-19 vaccine boosters on systemic and mucosal antibody and T cell immunity
Kronsteiner, B., Govender, M., Liu, C., Dijokaite-Guraliuc, A., Ali, M., Hill, J. W., Zewdie, M., Cross, A., Austin, J. A., Watts, A., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-28310-0 · Cited by 2
Longitudinal trends in the endemic symptomatic burden of COVID-19: Insights from community-based participatory virological surveillance in the Netherlands, November 2020-April 2025
Carstens, G., Han, W. G. H., Timmermanns, L., van den Hof, S., Eggink, D., & van Hoek, A. J. (2025) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2025.108264 · Cited by 2
First-in-human clinical trial of high-dose sodium copper chlorophyllin: Pharmacology and efficacy as a dual immunomodulatory/antiviral agent
Patwardhan, R. S., Rizvi, Z. A., Gota, V., Checker, R., Singh, B., Maurya, D. K., Pal, D., Ramani, N., Kumar, B. K., Purohit, V., et al. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157689 · Cited by 2
Molecular characterization and pathogenicity of a novel Chinese porcine deltacoronavirus strain CH/HLJ/20 isolated from diarrheic piglets
Wang, Y., Ma, X., Zhang, H., Xue, X., Li, J., Jiang, Y., Cui, W., Liu, D., Zhou, B., & Wang, L. (2025) · Virulence · doi:10.1080/21505594.2025.2605366 · Cited by 2
From host to population: Bridging the viral immuno-evolutionary gap
Jamaleddine, H., Grenfell, B. T., Graham, A. L., & Mandl, J. N. (2025) · Immunity · doi:10.1016/j.immuni.2025.12.001 · Cited by 3
The evolutionary landscape and serotypic dynamics of avian infectious bronchitis virus from spike protein
Zhang, H., Han, Z., Zou, C., Huang, Y., Sun, S., Peng, O., Ashraf, U., Xu, Q., Ge, Y., Kang, Q., et al. (2026) · iMetaOmics. · doi:10.1002/imo2.70077 · Cited by 2
Engineered mucus-tethering bispecific nanobodies enhance mucosal immunity against respiratory pathogens
Zhao, L., O’Donnell, K. L., Dubey, M., Wang, Y., Martinez, N. R., Zhang, Y., Steininger, H. M., Ma, C., Mallajosyula, V. V. A., Lee, L. L. Y., et al. (2026) · Nature Nanotechnology · doi:10.1038/s41565-025-02107-8 · Cited by 2
Central role of glycosylation processes in human genetic susceptibility to SARS-CoV-2 infections with Omicron variants
Frank, G., Wu, X., Lammi, V., Abner, E., Valliere, J. T., Nastou, K. C., Burns, A. C., Rasmussen, M., Andersson, N. W., Quinn, L. J. E., et al. (2026) · Nature Genetics · doi:10.1038/s41588-025-02484-9 · Cited by 2
In silico assessment of cyanobacterial alkaloids as probable medications against SARS-CoV-2
Sen, A., Chanda, H. M. K. C., Cheemanapalli, S., Umamaheswari, A., Rath, J., & Joardar, N. (2026) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2026.100215 · Cited by 2
Hydrogen–Deuterium Exchange Mass Spectrometry Reveals an Antibody-Induced Allosteric Pathway Driving SARS-CoV-2 Spike Trimer Disassembly
Luo, Y., Liu, B., Liu, R., Chen, Q., Xiong, X., & Li, H. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.5c18784 · Cited by 3
Nationwide wastewater sequencing surveillance of SARS-CoV-2 lineages: validation against clinical data across 28 U.S. states
Zulli, A., White, B. J., Duong, D. H., Shelden, B., Chan-Herur, V., Wolfe, M. K., & Boehm, A. B. B. (2026) · PeerJ · doi:10.7717/peerj.20941 · Cited by 2
Tracking viral variants by wastewater surveillance, from laboratory diagnosis towards on-site monitoring: lessons learned from the SARS-CoV-2 pandemic
Zhang, Q., Gao, C., Ge, X., Sun, Y., Liu, P., & Zhang, X.-X. (2026) · Journal of Environmental Management · doi:10.1016/j.jenvman.2026.129353 · Cited by 2
Rage against the mean: a perspective on measuring fitness of individual phage particles
Antani, J. D., & Turner, P. E. (2026) · npj Viruses · doi:10.1038/s44298-026-00187-4 · Cited by 2
Genomic-epidemiological analysis of 15 million SARS-CoV-2 genomes reveals accelerated fitness gain of JN.1 lineage
Lei, Z.-Y., Jin, Q.-T., Zhang, X., Bo, X., Ren, Z.-L., Tong, Y.-G., & Ni, M. (2026) · Virologica Sinica · doi:10.1016/j.virs.2026.03.015 · Cited by 2
2‐Phenylquinolines Exhibit Anti‐Severe Acute Respiratory Syndrome Coronavirus‐2 Activity Through the Nonstructural Protein 13 Helicase Inhibition
Cernicchi, G., Nizi, M. G., Emmolo, R., Persoons, L., Laporte, M., Jochmans, D., Romeo, I., Pepe, G., Milite, C., Campiglia, P., et al. (2026) · ChemMedChem · doi:10.1002/cmdc.202501063 · Cited by 2
Rapid screening of animal coronaviruses in livestock and wildlife using a silicon photonics biosensor
Serrano, B., Soler, M., Courtillon, C., Allée, C., Monastiri, A., López-Roig, M., Cobo, J. S., & Lechuga, L. M. (2026) · npj Biosensing · doi:10.1038/s44328-026-00091-0 · Cited by 2
Machine Learning-Driven Simulations of the SARS-CoV-2 Fitness Landscape from Deep Mutational Scanning Experiments
Durumeric, A. E. P., McCarty, S., Smith, J., Köhler, J., Elez, K., Raich, L., Suriana, P., & Sztain, T. (2026) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6c00332 · Cited by 2
Neutralizing antibodies response to novel SARS-CoV-2 omicron sublineages in long-term care facility residents after the fourth dose of monovalent BNT162b2 COVID-19 vaccination
Varasi, I., Lai, A., Fiaschi, L., Bergna, A., Gatti, A., Caimi, B., Biba, C., Ventura, C. D., Balotta, C., Riva, A., et al. (2023) · Journal of Infection · doi:10.1016/j.jinf.2023.06.019 · Cited by 2
A collaborative approach to improving representation in viral genomic surveillance
Kim, P., Kim, A. Y., Newman, J. J., Cella, E., Bishop, T. C., Huwe, P. J., Uchakina, O. N., McKallip, R. J., Mack, V. L., Hill, M. P., et al. (2023) · PLOS Global Public Health · doi:10.1371/journal.pgph.0001935 · Cited by 2
How to better select SARS‐CoV‐2 preservation solution of virus nucleic acid testing
Duan, X., Huang, L., Wang, X., Ping, Y., Pan, Y., Liu, W., Xie, Y., & Tao, Z. (2023) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24956 · Cited by 1
Lymphopenia associated with survivin and its downstream pathway in COVID-19 serving as a potential route in COVID-19 pathogenesis
Kahrizi, M. S., Nasiri, K., Ebrahimzadeh, F., Yaseri, A. F., Ghodratizadeh, S., Gholamrezaei, M., Dahmardeh, A. R., Adili, A., Amjidifar, R., Hemmatzadeh, M., et al. (2024) · Advances in Medical Sciences · doi:10.1016/j.advms.2024.03.006 · Cited by 2
Exploration of low-frequency allelic variants of SARS-CoV-2 genomes reveals coinfections in Mexico occurred during periods of VOCs turnover
García-López, R., Taboada, B., Zárate, S., Muñoz‐Medina, J. E., Salas-Lais, Á. G., Herrera‐Estrella, A., Boukadida, C., Vázquez-Pérez, J. A., Gómez‐Gil, B., Sánchez‐Flores, A., et al. (2024) · Microbial Genomics · doi:10.1099/mgen.0.001220 · Cited by 2
Clinical and prognostic implications of hyaluronic acid in patients with COVID-19 reinfection and first infection
Li, Y., Han, M., & Li, X. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1406581 · Cited by 2
SARS-CoV-2 Molecular Evolution: A Focus on Omicron Variants in Umbria, Italy
Bicchieraro, G., Ciurnelli, R., Graziani, A., Wong, A. Y. W., Camilloni, B., Mencacci, A., & Spaccapelo, R. (2024) · Microorganisms · doi:10.3390/microorganisms12071330 · Cited by 2
In Silico and In Vitro Studies of Terpenes from the Fabaceae Family Using the Phenotypic Screening Model against the SARS-CoV-2 Virus
de Sousa, N. F., Duarte, G. D., Moraes, C. B., Barbosa, C. G., Martin, H., Muratov, N. N., do Nascimento, Y. M., Scotti, L., Freitas-Junior, L. H., Barbosa‐Filho, J. M., et al. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16070912 · Cited by 2
The COVID ‐19 pandemic as a modifier of DGBI symptom severity: A systematic review and meta‐analysis
Kulin, D., Shah, A., Fairlie, T., Wong, R. K. M., Fang, X., Ghoshal, U. C., Kashyap, P., Mulak, A., Lee, Y. Y., Talley, N. J., et al. (2024) · Neurogastroenterology & Motility · doi:10.1111/nmo.14878 · Cited by 2
Exploring the therapeutic efficacy: Unveiling the active compounds of Huashi Baidu granules against COVID-19
Tian, C., Zhao, J., Wang, Q., Luo, K., Zhao, S., Li, W., Wan, L., Ma, K., Yao, C., Zhou, Y., et al. (2024) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2024.105910 · Cited by 2
Interaction of Receptor-Binding Domain of the SARS-CoV-2 Omicron Variant with hACE2 and Actin
Fujimoto, A., Kawai, H., Kawamura, R., & Kitamura, A. (2024) · Cells · doi:10.3390/cells13161318 · Cited by 2
A compartmental model for the dynamic simulation of pandemics with a multi-phase vaccination and its application to Italian COVID-19 data
Cerqueti, R., Ramponi, A., & Scarlatti, S. (2024) · Mathematics and Computers in Simulation · doi:10.1016/j.matcom.2024.08.011 · Cited by 2
Intranasal Self-Adjuvanted Lipopeptide Vaccines Elicit High Antibody Titers and Strong Cellular Responses against SARS-CoV-2
Maxwell, J. W. C., Stockdale, S., Stewart, E. L., Ashley, C. L., Smith, L. J., Steain, M. C., Triccas, J. A., Byrne, S. N., Britton, W. J., Ashhurst, A. S., et al. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c00544 · Cited by 2
SARS-CoV-2 JN.1 variant: a short review
Malay, S., Madabhavi, I., & Tripathi, A. (2024) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2024.2981 · Cited by 2
Stability of Envelope Proteins of SARS-CoV-2 Variants Could Be a Choice of New Drug Target
Khan, A. S., Angel, B., Angel, A., Joshi, V., Shareef, B., Khaneja, P., Sharma, B., Peer, N. M., Singh, N., Barthwal, S., et al. (2024) · International Journal of experimental research and review · doi:10.52756/ijerr.2024.v42.010 · Cited by 2
Current status and clinical outcomes of pharmacotherapies according to SARS-CoV-2 mutations in patients with mild-to-moderate COVID-19: a retrospective single center study
Park, S., Je, N. K., Kim, D. W., Park, M., & Heo, J. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-09765-4 · Cited by 2
Impact analysis of SARS-CoV-2 vaccination in patients treated with monoclonal antibodies: A monocentric experience
Perrotta, N., Fiorito, L. A., Leanza, C., Bari, S. D., Casini, G., Gentile, R., Vescovo, R., Piciocchi, A., Ajassa, C., Iaiani, G., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113101 · Cited by 2
Disulfide Bond Engineering of Soluble ACE2 for Thermal Stability Enhancement
Ys, K., Kim, M., Park, H. M., Kim, H. J., & Ryu, S. E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25189919 · Cited by 2
Immunogenicity and Safety of Omicron-Containing Multivalent COVID-19 Vaccines in Unvaccinated and Previously Vaccinated Adults
Hannawi, S., Abuquta, A., Eldin, L. S., Hassan, A., Alamadi, A., Gao, C., Baidoo, A. A. H., Yang, X., Su, H., Zhang, J., et al. (2024) · Vaccines · doi:10.3390/vaccines12101109 · Cited by 2
The Influence of Initial Immunosuppression on the Kinetics of Humoral Response after SARS-CoV-2 Vaccination in Patients Undergoing Kidney Transplantation
Foresto, R. D., Souza, R. M., dos Anjos, G. R., Nakamura, M. R., Goulart, H. D. S., Sampaio, R., França, D. P., Marques, E. F., Lucena, E. F., Cristelli, M. P., et al. (2024) · Vaccines · doi:10.3390/vaccines12101135 · Cited by 2
In Silico Design of miniACE2 Decoys with In Vitro Enhanced Neutralization Activity against SARS-CoV-2, Encompassing Omicron Subvariants
Romero, J. A. A., López-Cantillo, G., Moreno-Jiménez, S., Marcos‐Alcalde, Í., Ros‐Pardo, D., Camacho, B., Gómez‐Puertas, P., & Ramirez-Segura, C. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910802 · Cited by 2

Authors: Markov, P. V., Ghafari, M., Beer, M., Lythgoe, K., Simmonds, P., Stilianakis, N. I., & Katzourakis, A.
Affiliations: University of London (GB)
University of Oxford (GB)
Friedrich-Loeffler-Institut (DE)
Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
Corresponding author: Markov, Peter V.
Katzourakis, Aris
ORCID: Markov, Peter V.
Ghafari, Mahan
Beer, Martin
Lythgoe, Katrina
Stilianakis, Nikolaos I.
Katzourakis, Aris
Venue: Nature Reviews Microbiology
Publisher: Springer Science and Business Media LLC
Published: 2023-04-05
Volume: 21
Issue: 6
Pages: 361-379
ISSN: 1740-1526 (ISSN-L)
1740-1534
DOI: 10.1038/s41579-023-00878-2
OpenAlex: W4362609000
Semantic Scholar: b6c3324e790174aac7a7b28fcfe0bc22f5461418
Cited by: 1,179
References: 225
Citations by year: 2026: 204 · 2025: 390 · 2024: 441 · 2023: 130
FWCI: 55.63
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Nature Reviews Microbiology (publishedVersion)
PubMed (publishedVersion)
LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
OpenAgrar (submittedVersion)
Funders: Wellcome Trust (107652/Z/15/Z)
H2020 European Research Council (101001623)
Topics: Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
Keywords: SARS-CoV-2, viral evolution, genetic variation, variants of concern, antigenic evolution, immune evasion, reinfection, recombination, chronic infection, reservoir hosts, transmissibility, disease severity, COVID-19 pandemic, evolutionary trajectories
MeSH terms: COVID-19, SARS-CoV-2, Animals, Genomics, Immune Evasion, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The evolution of SARS-CoV-2

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks